Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia, and Malaysia. The company is headquartered in Ottawa, Canada.
Frequently asked questions
What sector does Avivagen Inc (VIVXF) operate in?
Avivagen Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Avivagen Inc (VIVXF) current stock price?
As of the latest data, Avivagen Inc stock price is $0.00, with a previous close of $0.00.
What is Avivagen Inc (VIVXF) current market capitalization?
Avivagen Inc market cap is approximately 7.77 thousand.
What is Avivagen Inc (VIVXF) Earnings Per Share (EPS)?
The trailing EPS is -$0.04.
Does Avivagen Inc (VIVXF) pay dividends?
No. Avivagen Inc does not pay a dividend.
What is Avivagen Inc (VIVXF) beta (volatility) score?
Avivagen Inc has a beta of -17.296, indicating lower volatility than the overall market.